CDX2 Antibody - Biocare Medical
A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis | SpringerLink
CDX1 and CDX2 immunohistochemistry and image analysis at different... | Download Scientific Diagram
Diagnostics | Free Full-Text | CDX2- and PAX8-Expressing Subtypes in Female Urethral Adenocarcinoma: Pathogenesis Insights through Immunohistochemical and Morphological Analyses
Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients
Differential expression of CK7, CK20, CDX2 in intestinal and pancreatobiliary types of preriampullary carcinoma
CDX2 marker as immunohistochemistry stain was positive as brown color... | Download Scientific Diagram
Prognostic value of low CDX2 expression in colorectal cancers with a high stromal content – a short report | Cellular Oncology
CDX2 (a, b) MUC2 (c, d) immunostaining patterns: a strong nuclear CDX2... | Download Scientific Diagram
Distribution of CDX2 expression in patients with colorectal cancer and... | Download Scientific Diagram
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer - Bruun - 2018 - Molecular Oncology - Wiley Online Library
CDX2 - an overview | ScienceDirect Topics
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer | NEJM
Combination of CDX2 expression and T stage improves prognostic prediction of colorectal cancer - Weimin Xu, Yilian Zhu, Wei Shen, Wenjun Ding, Tingyu Wu, Yuegui Guo, Xiaobing Chen, Mingxia Zhou, Yingwei Chen,
Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts | British Journal of Cancer
CDX2 - TSGP | PathnSitu Biotechnologies
CDX2 controls genes involved in the metabolism of 5-fluorouracil and is associated with reduced efficacy of chemotherapy in colorectal cancer - ScienceDirect
The origin of p40-negative and CDX2-positive primary squamous cell carcinoma of the stomach: case report | World Journal of Surgical Oncology | Full Text
CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression | Cell Death & Disease
Current Oncology | Free Full-Text | Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour—State of the Art and Perspectives
CDX2, CK7 and CK20 staining in distant metastases of | Download Table
Mismatch repair phenotype determines the implications of tumor grade and CDX2 expression in stage II–III colon cancer - Modern Pathology
Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
Gastric-immunophenotype tumour end with CDX2 expression. Tumour cells... | Download Scientific Diagram
